GB9503850D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9503850D0
GB9503850D0 GBGB9503850.1A GB9503850A GB9503850D0 GB 9503850 D0 GB9503850 D0 GB 9503850D0 GB 9503850 A GB9503850 A GB 9503850A GB 9503850 D0 GB9503850 D0 GB 9503850D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9503850.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9503850.1A priority Critical patent/GB9503850D0/en
Publication of GB9503850D0 publication Critical patent/GB9503850D0/en
Priority to CA002213621A priority patent/CA2213621A1/en
Priority to EP96904846A priority patent/EP0810873A1/en
Priority to PCT/EP1996/000736 priority patent/WO1996026734A1/en
Priority to JP8525996A priority patent/JPH11501303A/en
Priority to AU48794/96A priority patent/AU4879496A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
GBGB9503850.1A 1995-02-25 1995-02-25 Medicaments Pending GB9503850D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9503850.1A GB9503850D0 (en) 1995-02-25 1995-02-25 Medicaments
CA002213621A CA2213621A1 (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir
EP96904846A EP0810873A1 (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir
PCT/EP1996/000736 WO1996026734A1 (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir
JP8525996A JPH11501303A (en) 1995-02-25 1996-02-22 Combination of antiviral agent consisting of BCH-189 and ritona beer
AU48794/96A AU4879496A (en) 1995-02-25 1996-02-22 Antiviral combinations of bch-189 and ritonavir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9503850.1A GB9503850D0 (en) 1995-02-25 1995-02-25 Medicaments

Publications (1)

Publication Number Publication Date
GB9503850D0 true GB9503850D0 (en) 1995-04-19

Family

ID=10770279

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9503850.1A Pending GB9503850D0 (en) 1995-02-25 1995-02-25 Medicaments

Country Status (6)

Country Link
EP (1) EP0810873A1 (en)
JP (1) JPH11501303A (en)
AU (1) AU4879496A (en)
CA (1) CA2213621A1 (en)
GB (1) GB9503850D0 (en)
WO (1) WO1996026734A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049411A1 (en) 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
FR2779653B1 (en) * 1998-06-11 2002-12-20 Inst Nat Sante Rech Med USE OF PROTEASOME MODULATING COMPOUNDS IN THERAPY
FR2878747B1 (en) * 2004-12-03 2007-03-30 Pierre Fabre Medicament Sa USE OF OMEGA-3 FATTY ACID (S) FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA CAUSED BY ANTI-RETROVIRAL TREATMENT IN HIV INFECTED PATIENTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010496A1 (en) * 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
DE19875016I2 (en) * 1991-05-16 2004-07-01 Glaxo Group Ltd Antivirus preparations containing nucleoside analogs.
DK0639971T3 (en) * 1992-05-13 2000-03-20 Wellcome Found Therapeutic combinations
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
UA49803C2 (en) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Method for treatment of retrovirus infections

Also Published As

Publication number Publication date
WO1996026734A1 (en) 1996-09-06
AU4879496A (en) 1996-09-18
JPH11501303A (en) 1999-02-02
EP0810873A1 (en) 1997-12-10
CA2213621A1 (en) 1996-09-06

Similar Documents

Publication Publication Date Title
HUP9801151A3 (en) Long-shelf-life medicaments
ZA966969B (en) Medicaments
GB9419536D0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9526392D0 (en) Medicaments
GB9503850D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9519029D0 (en) Medicaments
GB9504153D0 (en) Medicaments
GB9515628D0 (en) Medicaments
GB9514723D0 (en) Medicaments
GB9524173D0 (en) Medicaments
GB9506122D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9517021D0 (en) Medicaments
GB9523453D0 (en) Medicaments
GB9519021D0 (en) Medicaments
GB9521208D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) Medicaments